HOTH logo

Hoth Therapeutics, Inc. Common Stock


HOTH: Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.


Show HOTH Financials

Consumer Interest
SEC Filings

Recent trades of HOTH by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by HOTH's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of HOTH in WallStreetBets Daily Discussion


Recent insights relating to HOTH

CNBC Recommendations

Recent picks made for HOTH stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in HOTH

Corporate Flights

Flights by private jets registered to HOTH